ORDER
INFORMATION
| Catalog No: |
Product Description: |
Pack Size: |
| HDL 50 |
CHOLESTEROL HDL |
2 X 25 ML |
METHOD
Colorimetric endpoint test
PRINCIPLE
Low density lipoproteins (LDL and VLDL) and chylomicron fractions
are precipitated by buffered phosphotungstic acid reagent. After centrifugation,
the cholesterol concentration in the HDL (high density lipoprotein)
fraction, remains in the supernatant. Cholesterol included in this
phase, is determined by an enzymatic method.
SAMPLE:
Serum or EDTA plasma.
REFERENCE VALUES
| MEN |
41.0 - 58.7 mg/dl |
| WOMEN |
48.8 - 75.0 mg/dl |
QUALITY CONTROL
Accutestrol N - H
REAGENTS
Reagent I : Buffered phosphotungstic acid reagent
Cholesterol standard : 50 mg/dl
REAGENT PREPARATION
Ready to use.
STABILITY :
the contents are ready to use and is stable upto the expiry date when
stored at 2-8°C.
PRECIPITATION METHOD
Pipette into centrifugate tubes
| SAMPLE |
REAGENT |
| 500 µl |
500 µl |
|
Mix and allow to stand for 5 min. centrifugate
for 10 min at 3000 rpm and determine the cholesterol content by the
CHOD-PAP method. Only clear supernatant must be used.
AUTOMATED PARAMETERS
| Wave length |
520 nm |
| Reaction Type |
End Point |
| Cuvette |
1 cm light path |
| Reaction Temperature |
37°C |
| Reaction Type |
Increasing |
| Measurement |
Against Reagent Blank |
| Sample/Reagent Ratio |
1: 20 |
| Incubation |
5 minutes |
| Maximum Reagent Blank |
0.50 |
| Low Normal at 37°C |
41 mg/dl |
| High Normal at 37°C |
75 mg/dl |
| Linearity at 37°C |
200 mg/dl |
MANUAL PROCEDURE
PIPETTE INTO TEST TUBE
| |
BLANK |
STD |
SAMPLE |
| Sample |
- |
- |
50 µl |
| Standard |
- |
50 µl |
- |
| Reagent |
1000 µl |
1000 µl |
1000 µl |
Mix incubate for 5 min at 37°C (10 min at 20 - 25°C).
Measure absorbance of sample (Ac) and standard (As) against
the reagent blank.
The colour is stable for 90 min at 20 - 25°C.
CALCULATION AND LINEARITY
Ac/As
x Conc. Standard x 2 = mg% HDL in serum
2 = dilution factor of the Precipitation step |
The method is linear to a concentration of 200 mg/dl.
REFERENCES
Denacherp N.M., Hijans A.G.M., Vos-janseen H.E., Vant Laar A.P., Clin.
Chem., 26 1775 (1980)
Casteli W.P., : Current Prescribing, 3, 39 (1977). |